Healthcare -
Biotechnology - NYSE - US
$ 1.75
-4.37 %
$ 34.1 M
Market Cap
-0.41
P/E
ANVS - OPERATING INCOME
Operating Income ANVS - Annovis Bio, Inc.
-45 M
LAST VALUE
-76.01%
2 YEAR CAGR
-129.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR